These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24342414)

  • 21. Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?
    Lerman A; Holmes DR; Herrmann J; Gersh BJ
    Eur Heart J; 2007 Apr; 28(7):788-97. PubMed ID: 17347176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathology of coronary microembolisation and no reflow.
    Falk E; Thuesen L
    Heart; 2003 Sep; 89(9):983-5. PubMed ID: 12923001
    [No Abstract]   [Full Text] [Related]  

  • 23. Coronary microvascular dysfunction in patients with cardiac syndrome X: Ongoing debate.
    Celik T; Ozturk C; Balta S; Demirkol S; Iyisoy A
    Int J Cardiol; 2016 Sep; 218():233-234. PubMed ID: 27236120
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiac findings in asymptomatic chronic hemodialysis patients with persistently elevated cardiac troponin I levels.
    Katerinis I; Nguyen QV; Magnin JL; Descombes E
    Ren Fail; 2008; 30(4):357-62. PubMed ID: 18569907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative assessment of coronary microvascular function in patients with and without epicardial atherosclerosis.
    Melikian N; Vercauteren S; Fearon WF; Cuisset T; MacCarthy PA; Davidavicius G; Aarnoudse W; Bartunek J; Vanderheyden M; Wyffels E; Wijns W; Heyndrickx GR; Pijls NH; de Bruyne B
    EuroIntervention; 2010 Apr; 5(8):939-45. PubMed ID: 20542779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The "slow coronary flow" phenomenon: evidence of preserved coronary flow reserve despite increased resting microvascular resistances.
    Fineschi M; Bravi A; Gori T
    Int J Cardiol; 2008 Jul; 127(3):358-61. PubMed ID: 17651842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current diagnosis and clinical prognostic value of kidney dysfunction in patients with coronary heart disease].
    Shafranskaia KS; Bykova IS
    Ter Arkh; 2014; 86(6):94-9. PubMed ID: 25095663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How to study coronary microvascular dysfunction and its clinical relevance.
    L'Abbate A; Sambuceti G
    Ital Heart J; 2002 Apr; 3(4):230-6. PubMed ID: 12025371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The renal patient with coronary artery disease: current concepts and dilemmas.
    Gupta R; Birnbaum Y; Uretsky BF
    J Am Coll Cardiol; 2004 Oct; 44(7):1343-53. PubMed ID: 15464310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of circulation disorder in coronary slow flow by fundus fluorescein angiography.
    Koç S; Ozin B; Altın C; Altan Yaycıoğlu R; Aydınalp A; Müderrisoglu H
    Am J Cardiol; 2013 Jun; 111(11):1552-6. PubMed ID: 23538021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronary microvascular dysfunction in primary cardiomyopathies.
    Spoladore R; Fisicaro A; Faccini A; Camici PG
    Heart; 2014 May; 100(10):806-13. PubMed ID: 23904360
    [No Abstract]   [Full Text] [Related]  

  • 32. A simple thermodilution technique to assess coronary endothelium-dependent microvascular function in humans: validation and comparison with coronary flow reserve.
    Melikian N; Kearney MT; Thomas MR; De Bruyne B; Shah AM; MacCarthy PA
    Eur Heart J; 2007 Sep; 28(18):2188-94. PubMed ID: 17644509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The importance of choosing the right stress test for a correct prognosis.
    Rigo F; Grolla E
    J Cardiovasc Med (Hagerstown); 2012 Aug; 13(8):481-2. PubMed ID: 22767011
    [No Abstract]   [Full Text] [Related]  

  • 34. Coronary microvascular dysfunction and ventricular noncompaction: the chicken or the egg, or both the consequence of a certain undetermined cause?
    Song ZZ
    Cardiol Young; 2008 Oct; 18(5):549-50. PubMed ID: 18706135
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapeutic advances in myocardial microvascular resistance: unravelling the enigma.
    Patel B; Fisher M
    Pharmacol Ther; 2010 Aug; 127(2):131-47. PubMed ID: 20546779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mild chronic kidney dysfunction and treatment strategies for stable coronary artery disease.
    Lopes NH; da Silva Paulitsch F; Pereira A; Garzillo CL; Ferreira JF; Stolf N; Hueb W
    J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1443-9. PubMed ID: 19464462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and treatment of coronary artery disease in patients with chronic kidney disease: Ischaemic heart disease.
    Johnston N; Dargie H; Jardine A
    Heart; 2008 Aug; 94(8):1080-8. PubMed ID: 18625799
    [No Abstract]   [Full Text] [Related]  

  • 38. Varying prognostic significance of "ischemic ST depression" during vasodilator stress testing in patients with normal SPECT/PET myocardial perfusion imaging.
    Piotrowicz R
    Cardiol J; 2009; 16(2):101-4. PubMed ID: 19387955
    [No Abstract]   [Full Text] [Related]  

  • 39. Perspectives in the management of chronic coronary artery disease.
    Fass AE
    Heart Dis; 2003; 5(6):365-7. PubMed ID: 14633316
    [No Abstract]   [Full Text] [Related]  

  • 40. Coronary microvascular dysfunction in patients with diabetes, hypertension and metabolic syndrome.
    Sucato V; Novo G; Evola S; Novo S
    Int J Cardiol; 2015; 186():96-7. PubMed ID: 25814352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.